Literature DB >> 10376605

Binding of TBP to promoters in vivo is stimulated by activators and requires Pol II holoenzyme.

L Kuras1, K Struhl.   

Abstract

In eukaryotes, transcriptional activators have been proposed to function by recruiting the RNA polymerase II (Pol II) machinery, by altering the conformation of this machinery, or by affecting steps after initiation, but the evidence is not definitive. Genomic footprinting of yeast TATA-box elements reveals activator-dependent alterations of chromatin structure and activator-independent protection, but little is known about the association of specific components of the Pol II machinery with promoters in vivo. Here we analyse TATA-box-binding-protein (TBP) occupancy of 30 yeast promoters in vivo. We find that TBP association with promoters is stimulated by activators and inhibited by the Cyc8-Tup1 repressor, and that transcriptional activity correlates strongly with the degree of TBP occupancy. In a small subset of promoters, TBP occupancy is higher than expected when gene activity is low, and the activator-dependent increase is modest. TBP association depends on the Pol II holoenzyme component Srb4, but not on the Kin28 subunit of the transcription factor TFIIH, even though both proteins are generally required for transcription. Thus in yeast cells, TBP association with promoters occurs in concert with the Pol II holoenzyme, activator-dependent recruitment of the Pol II machinery occurs at the vast majority of promoters, and Kin28 acts after the initial recruitment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376605     DOI: 10.1038/21239

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  241 in total

1.  The Spt components of SAGA facilitate TBP binding to a promoter at a post-activator-binding step in vivo.

Authors:  A M Dudley; C Rougeulle; F Winston
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

2.  Remodeling of yeast CUP1 chromatin involves activator-dependent repositioning of nucleosomes over the entire gene and flanking sequences.

Authors:  C H Shen; B P Leblanc; J A Alfieri; D J Clark
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

3.  Histone acetylation at promoters is differentially affected by specific activators and repressors.

Authors:  J Deckert; K Struhl
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

4.  Drosophila Mediator complex is broadly utilized by diverse gene-specific transcription factors at different types of core promoters.

Authors:  J M Park; B S Gim; J M Kim; J H Yoon; H S Kim; J G Kang; Y J Kim
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

5.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

Authors:  Y Takahashi; J B Rayman; B D Dynlacht
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

6.  Srb7p is a physical and physiological target of Tup1p.

Authors:  A Gromöller; N Lehming
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

7.  Interaction of a transcriptional repressor with the RNA polymerase II holoenzyme plays a crucial role in repression.

Authors:  Z Zaman; A Z Ansari; S S Koh; R Young; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

8.  Histone-dependent association of Tup1-Ssn6 with repressed genes in vivo.

Authors:  Judith K Davie; Robert J Trumbly; Sharon Y R Dent
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

9.  H2A.Z is required for global chromatin integrity and for recruitment of RNA polymerase II under specific conditions.

Authors:  M Adam; F Robert; M Larochelle; L Gaudreau
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

10.  Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors.

Authors:  Yael Katan-Khaykovich; Kevin Struhl
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.